166 related articles for article (PubMed ID: 36626550)
21. Zyxin is a transforming growth factor-β (TGF-β)/Smad3 target gene that regulates lung cancer cell motility via integrin α5β1.
Mise N; Savai R; Yu H; Schwarz J; Kaminski N; Eickelberg O
J Biol Chem; 2012 Sep; 287(37):31393-405. PubMed ID: 22778267
[TBL] [Abstract][Full Text] [Related]
22. Functional characterization of transforming growth factor beta signaling in Smad2- and Smad3-deficient fibroblasts.
Piek E; Ju WJ; Heyer J; Escalante-Alcalde D; Stewart CL; Weinstein M; Deng C; Kucherlapati R; Bottinger EP; Roberts AB
J Biol Chem; 2001 Jun; 276(23):19945-53. PubMed ID: 11262418
[TBL] [Abstract][Full Text] [Related]
23. Fusion proteins of retinoid receptors antagonize TGF-beta-induced growth inhibition of lung epithelial cells.
La P; Morgan TA; Sykes SM; Mao H; Schnepp RW; Petersen CD; Hua X
Oncogene; 2003 Jan; 22(2):198-210. PubMed ID: 12527889
[TBL] [Abstract][Full Text] [Related]
24. Roles of Smad3 in TGF-beta signaling during carcinogenesis.
Millet C; Zhang YE
Crit Rev Eukaryot Gene Expr; 2007; 17(4):281-93. PubMed ID: 17725494
[TBL] [Abstract][Full Text] [Related]
25. Reversible Smad-dependent signaling between tumor suppression and oncogenesis.
Sekimoto G; Matsuzaki K; Yoshida K; Mori S; Murata M; Seki T; Matsui H; Fujisawa J; Okazaki K
Cancer Res; 2007 Jun; 67(11):5090-6. PubMed ID: 17545585
[TBL] [Abstract][Full Text] [Related]
26. TGF-β-activated SMAD3/4 complex transcriptionally upregulates N-cadherin expression in non-small cell lung cancer.
Yang H; Wang L; Zhao J; Chen Y; Lei Z; Liu X; Xia W; Guo L; Zhang HT
Lung Cancer; 2015 Mar; 87(3):249-57. PubMed ID: 25595426
[TBL] [Abstract][Full Text] [Related]
27. Oncogenic Smad3 signaling induced by chronic inflammation is an early event in ulcerative colitis-associated carcinogenesis.
Kawamata S; Matsuzaki K; Murata M; Seki T; Matsuoka K; Iwao Y; Hibi T; Okazaki K
Inflamm Bowel Dis; 2011 Mar; 17(3):683-95. PubMed ID: 20602465
[TBL] [Abstract][Full Text] [Related]
28. c-Jun N-terminal kinase 1 promotes transforming growth factor-β1-induced epithelial-to-mesenchymal transition via control of linker phosphorylation and transcriptional activity of Smad3.
Velden JL; Alcorn JF; Guala AS; Badura EC; Janssen-Heininger YM
Am J Respir Cell Mol Biol; 2011 Apr; 44(4):571-81. PubMed ID: 20581097
[TBL] [Abstract][Full Text] [Related]
29. RasV12-mediated down-regulation of CCAAT/enhancer binding protein beta in immortalized fibroblasts requires loss of p19Arf and facilitates bypass of oncogene-induced senescence.
Sebastian T; Johnson PF
Cancer Res; 2009 Mar; 69(6):2588-98. PubMed ID: 19276382
[TBL] [Abstract][Full Text] [Related]
30. Smad4/DPC4 silencing and hyperactive Ras jointly disrupt transforming growth factor-beta antiproliferative responses in colon cancer cells.
Calonge MJ; Massagué J
J Biol Chem; 1999 Nov; 274(47):33637-43. PubMed ID: 10559252
[TBL] [Abstract][Full Text] [Related]
31. TGF-beta-mediated activation of RhoA signalling is required for efficient (V12)HaRas and (V600E)BRAF transformation.
Fleming YM; Ferguson GJ; Spender LC; Larsson J; Karlsson S; Ozanne BW; Grosse R; Inman GJ
Oncogene; 2009 Feb; 28(7):983-93. PubMed ID: 19079344
[TBL] [Abstract][Full Text] [Related]
32. Transforming growth factor-beta inhibits pulmonary surfactant protein B gene transcription through SMAD3 interactions with NKX2.1 and HNF-3 transcription factors.
Li C; Zhu NL; Tan RC; Ballard PL; Derynck R; Minoo P
J Biol Chem; 2002 Oct; 277(41):38399-408. PubMed ID: 12161428
[TBL] [Abstract][Full Text] [Related]
33. Transforming growth factor-beta1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-kappaB, JNK, and Ras signaling pathways.
Park JI; Lee MG; Cho K; Park BJ; Chae KS; Byun DS; Ryu BK; Park YK; Chi SG
Oncogene; 2003 Jul; 22(28):4314-32. PubMed ID: 12853969
[TBL] [Abstract][Full Text] [Related]
34. Attenuation of TGF-β signaling suppresses premature senescence in a p21-dependent manner and promotes oncogenic Ras-mediated metastatic transformation in human mammary epithelial cells.
Lin S; Yang J; Elkahloun AG; Bandyopadhyay A; Wang L; Cornell JE; Yeh IT; Agyin J; Tomlinson G; Sun LZ
Mol Biol Cell; 2012 Apr; 23(8):1569-81. PubMed ID: 22357622
[TBL] [Abstract][Full Text] [Related]
35. A mechanism of repression of TGFbeta/ Smad signaling by oncogenic Ras.
Kretzschmar M; Doody J; Timokhina I; Massagué J
Genes Dev; 1999 Apr; 13(7):804-16. PubMed ID: 10197981
[TBL] [Abstract][Full Text] [Related]
36. Smad7 but not Smad6 cooperates with oncogenic ras to cause malignant conversion in a mouse model for squamous cell carcinoma.
Liu X; Lee J; Cooley M; Bhogte E; Hartley S; Glick A
Cancer Res; 2003 Nov; 63(22):7760-8. PubMed ID: 14633701
[TBL] [Abstract][Full Text] [Related]
37. Oncogenic ras and p53 cooperate to induce cellular senescence.
Ferbeyre G; de Stanchina E; Lin AW; Querido E; McCurrach ME; Hannon GJ; Lowe SW
Mol Cell Biol; 2002 May; 22(10):3497-508. PubMed ID: 11971980
[TBL] [Abstract][Full Text] [Related]
38. The tumor suppressor KLF11 mediates a novel mechanism in transforming growth factor beta-induced growth inhibition that is inactivated in pancreatic cancer.
Buck A; Buchholz M; Wagner M; Adler G; Gress T; Ellenrieder V
Mol Cancer Res; 2006 Nov; 4(11):861-72. PubMed ID: 17114344
[TBL] [Abstract][Full Text] [Related]
39. Requirement of Ras/MAPK pathway activation by transforming growth factor beta for transforming growth factor beta 1 production in a Smad-dependent pathway.
Yue J; Mulder KM
J Biol Chem; 2000 Oct; 275(40):30765-73. PubMed ID: 10843986
[TBL] [Abstract][Full Text] [Related]
40. Depletion of ERK2 but not ERK1 abrogates oncogenic Ras-induced senescence.
Shin J; Yang J; Lee JC; Baek KH
Cell Signal; 2013 Dec; 25(12):2540-7. PubMed ID: 23993963
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
